Structural variation and (+)-amphetamine-like discriminative stimulus properties

  title={Structural variation and (+)-amphetamine-like discriminative stimulus properties},
  author={Robert Oberlender and David E. Nichols},
  journal={Pharmacology Biochemistry and Behavior},
  • R. OberlenderD. Nichols
  • Published 1 March 1991
  • Biology, Chemistry, Psychology
  • Pharmacology Biochemistry and Behavior

Figures from this paper

Comparative studies on behavioral neurochemical effects of N,α-diethylphenethylamine and methamphetamine in rats

The results suggest that NADEP has significant psychostimulatory effects, though the effects were less than those of METH, and NADEP should be carefully monitored to avoid abuse as a psychoactive drug.

Amphetamine-like Neurochemical and Cardiovascular Effects of α-Ethylphenethylamine Analogs Found in Dietary Supplements

The results show that α-ethylphenethylamine analogs are biologically active, and although less potent than amphetamine, they produce cardiovascular effects that could pose risks to humans.

Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats

Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release

Interactions of 20 “bath salt” components with human dopamine, serotonin, and norepinephrine transporters heterologously expressed in human embryonic kidney 293 cells suggested thresholds of binding/uptake ratios above which compounds were likely to be substrates.

Synthetic Aminoindanes: A Summary of Existing Knowledge

Greater knowledge about aminoindanes is urgently required to decrease risks of fatal intoxication, and appropriate legislation is needed to protect public health without impeding research.

Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous 'others'.

These two articles may help suitable legislation to be rapidly devised to make the prohibition of DDs permanent whenever deemed necessary, as well as providing an up-to-date reference source for those engaged in the DD issue.

Designer phenethylamines routinely found in human urine: 2-ethylamino-1-phenylbutane and 2-amino-1-phenylbutane.

Two analytes identified by gas chromatography-mass spectrometry in multiple urine samples submitted for stimulant drug testing and screened positive for amphetamines by enzyme immunoassay are determined to be EAPB and its suggested metabolite APB.

Reinforcing Effects of Phenethylamine Analogs Found in Dietary Supplements

The effects of amphetamine and selected phenethylamine analogs are compared on drug self‐administration behavior in rats to show comparable pharmacological effects to Amphetamine and other stimulants.



(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.

The results support the hypothesis that the primary behavioral activity of MDMA-like compounds is unlike that of hallucinogens and stimulants and may represent the effects of a novel drug class, given the name entactogens.


Preliminary pharmacological evaluation revealed that racemic 2-ADN is approximately one-fourth as potent as (+)-amphetamine as a stimulant in mice.

Pharmacology of 2-amino-indane hydrochloride (Su-8629): a potent non-narcotic analgesic.

Su-8629 (2-amino-indane) has oral analgesic potency and a therapeutic index comparable to morphine sulfate; it is unlike morphine in that it does not depress respiration and is not antagonized by

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

It is suggested that this compound is the prototype of a new pharmacologic class that may have value in facilitating psychotherapy and that this class be designated as entactogens.

Amphetamines: Structure-Activity Relationships

Clinically, amphetamine has been used as a stimulant, antidepressant, and appetite suppressant, but with repeated administration tolerance frequently develops to many of its effects.